NLH Nova Leap Health Corp

NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), announced today that its shareholders voted in favour of all items of business brought before them at the Company’s annual and special meeting of shareholders held on June 28, 2023.

At the meeting, the six nominees to the Company’s Board of Directors, Chris Dobbin, Wayne Myles, Michael O’Keefe, Dana Hatfield, Marie Mullally and Anne Whelan, were elected for the ensuing year. Grant Thornton LLP was re-appointed as the Company’s auditor to hold office until the next annual meeting of shareholders or until its successor is duly appointed, at a remuneration to be fixed by the Board.

In addition, the second amended and restated equity incentive plan of the Company (the “Plan”), which amends and restates the Company’s existing amended and restated equity incentive plan, was approved and ratified. The principal amendment was to change the Plan to a 10% “rolling” plan, allowing for the issuance of stock options and deferred share units up to a maximum of 10% of the issued and outstanding common shares of the Company, and removing the fixed maximum number of common shares that may be issued upon redemption of deferred share units. More information on the Plan, including a copy of the Plan, is available in the Company’s Management Information Circular dated May 30, 2023 filed on SEDAR.

The voting results for the annual and special meeting of the shareholders held on June 28, 2023 were as follows:

MOTIONS		NUMBER OF SHARES								PERCENTAGE OF VOTES CAST
		FOR			AGAINST		WITHHELD/ ABSTAIN	SPOILED	NON VOTE	FOR		AGAINST		WITHHELD/
														ABSTAIN
Christopher Dobbin		40,101,920			152,560		0	0	0	99.62	%	0.38	%	0.00	%
Dana Hatfield		40,140,920			113,560		0	0	0	99.72	%	0.28	%	0.00	%
Michael O'Keefe		40,167,980			86,500		0	0	0	99.79	%	0.21	%	0.00	%
Wayne Myles		40,101,620			152,860		0	0	0	99.62	%	0.38	%	0.00	%
Marie Mullally		40,046,420			208,060		0	0	0	99.48	%	0.52	%	0.00	%
Anne Whelan		40,046,420			208,060		0	0	0	99.48	%	0.52	%	0.00	%
Appointment of Auditors		40,193,980			-		60,500	0	0	99.85	%	0.00	%	0.15	%
Approval of Second Amended and Restated Equity Incentive Plan		39,980,170			274,310		0	0	0	99.32	%	0.68	%	0.00	%

 

TOTAL SHAREHOLDERS VOTED BY PROXY:	64
TOTAL SHARES ISSUED & OUTSTANDING:	86,209,252
TOTAL SHARES VOTED:	40,254,480
TOTAL % OF SHARES VOTED:	46.69%

About Nova Leap

Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 ranking on the 2021 Report on Business ranking of Canada’s Top Growing Companies, the #2 ranking on the 2020 Report on Business ranking of Canada’s Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 10 different U.S. states within the New England, Southeastern, South Central and Midwest regions as well as in Nova Scotia, Canada.

CAUTIONARY STATEMENT:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

 

 

For further information:

Chris Dobbin, CPA, ICD.D
Director, President and CEO
T: 902 401 9480    
E:cdobbin@novaleaphealth.com